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Abstract
Background Bilateral thoracoscopic splanchnicectomy
(BTS) is a well-known technique to alleviate intractable
pain in patients with chronic pancreatitis. BTS not only
disrupts afferent fibers from the pancreas that mediate pain
but also postganglionic sympathetic fibers, which originate
in segments T5–T12 and which innervate the vasculature
of the liver, pancreas, and the adrenal gland. The purpose
of this study was to assess whether and how BTS affects
sympathetic noradrenergic and adrenomedullary function
in patients with chronic pancreatitis.
Methods Sixteen patients with chronic pancreatitis for at
least 1 year underwent autonomic function testing before
and 6 weeks after BTS for intractable pain. Testing was
performed during supine rest and during sympathetic
stimulation when standing.
Results Supine and standing systolic and diastolic blood
pressure were significantly lower post-BTS compared with
pre-BTS (P = 0.001). One patient showed orthostatic
hypotension after BTS. Baseline plasma norepinephrine
levels and plasma norepinephrine responses to sympathetic
activation during standing were not reduced by BTS. In
contrast, supine plasma epinephrine levels and responses
during standing were significantly reduced (P \ 0.001).
Parasympathetic activity was unaffected by BTS as shown
by unaltered Valsalva ratio, I-E difference, and DHRmax.
Conclusions BTS for pain relief in patients with chronic
pancreatitis reduced adrenomedullary function, due to
disruption of the efferent sympathetic fibers to the adrenal
gland. BTS did not affect noradrenergic sympathetic
activity, although blood pressure was lower after the
sympathectomy.
Keywords Sympathetic activity  Splanchnicectomy 
Thoracoscopy  Chronic pancreatitis
Chronic pancreatitis is a fibroinflammatory disease of the
pancreas. Pain is the main reason for these patients to seek
medical help. The goal of surgical therapy is to alleviate
pain, preferably without morbidity or mortality and with
preservation of pancreatic function. In the absence of an
anatomical substrate or when previous surgery has not been
successful, nerve interruption, such as celiac blockade or
splanchnicectomy, are recommended [1]. Bilateral tho-
racoscopic splanchnicectomy (BTS) is a minimally inva-
sive surgical procedure to dissect splanchnic nerves
through a thoracoscopic approach. BTS has the advantage
of low morbidity without reported mortality [2].
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and Other Interventional Techniques 
The splanchnic nerves predominantly consist of sym-
pathetic fibers and the contribution of visceral pain affer-
ents, which accompany the sympathetic nerves is relatively
small [3]. Sympathetic fibers, originating in segments T5–
T12, synapse in the celiac ganglia from where postgan-
glionic splanchnic fibers innervate the pancreatic and
intestinal vasculature [4] and the adrenal glands [5]. A
potentially undesired effect of BTS is an impairment of
cardiovascular homeostasis, particularly in chronic pan-
creatitis patients who often have cardiovascular and
respiratory comorbidity. Because the splanchnic vascular
bed has an important capacitance function, interrupting its
noradrenergic innervation by BTS might reduce the return
of venous blood to the heart, thus predisposing the patient
to orthostatic hypotension. In addition, dissecting the
sympathetic nerve to the adrenal gland might affect
adrenomedullary function. This study was designed to
assess the effects of BTS performed in patients with
chronic pancreatitis on sympathetic noradrenergic and
adrenal medullary baseline function before and after sym-
pathetic stimulation.
Patients and methods
Sixteen patients (10 men and 6 women), with chronic
pancreatitis for at least 1 year, who underwent bilateral
thoracoscopic splanchnicectomy (BTS) for disabling pain
were studied for the effects of sympathectomy on sympa-
thetic activity. Median age was 49 (range 32–68) years. All
patients had chronic pancreatitis, diagnosed by means of
endoscopic retrograde cholangiopancreaticography, com-
puted tomography, and/or magnetic resonance cholangio-
pancreaticography, according to standard criteria [6].
Based on these criteria, all but three patients had small-duct
disease. Fifteen patients were taking opioid medication.
Patients treated for hypertension or patients with medica-
tions that directly interfered with the sympathetic nervous
system were excluded. Demographic data and medication
are listed in Table 1. All patients gave their written,
informed consent for this study. The medical ethical
committee waved the need for protocol review.
Splanchnic denervation
We used a technique for BTS that was slightly modified from
that described by Cuschieri et al. [7]. In summary, the pro-
cedure is performed under general anesthesia with double-
lumen intubation for single-lung ventilation. The patient is
placed in a full prone position with the arms stretched along
the head. The thoracoscope is introduced two intercostal
spaces below the angle of the scapula, and a second trocar is
introduced one intercostal space above and a few inches
toward the spine. The parietal pleural space is opened from
the 5th to the 12th thoracic vertebra. To ensure complete
denervation, the splanchnic nerves and all of the potentially
nerve-bearing tissue on each side as well as the sympathetic
chain itself at level T5 are carefully transected by using the
harmonic scalpel (Ultracision, Johnson & Johnson Medi-
cals, Amersfoort, The Netherlands). At the end of the pro-
cedure, the lungs are reexpanded and the trocar sites closed
without routine use of chest drains.
Autonomic function testing
Sedative medication, which remained unaltered after the
operation, was stopped the day before testing, while anal-
gesic treatment was continued. All patients underwent
noninvasive measurement of blood pressure and heart rate
by the Finapres device (TNO, The Netherlands, model 5)
before and 6 weeks after BTS [8]. Blood pressure and heart
rate were measured after supine rest for 20 min. Thereafter,
the following tests for autonomic function were performed:
Standing up maneuver. Patients were asked to stand up
within 5 s and to remain in the upright position for 2 min.
The systolic (SBP) and diastolic blood pressure (DBP)
responses to the upright position were calculated from the
blood pressure values 50–80 s after standing up compared
with those of the supine rest position. Orthostatic hypo-
tension was defined as a decrease of systolic blood pressure
of more than 20 mmHg after standing. The difference
between the maximal heart rate at standing (15–20 s after
standing up) and the supine heart rate was calculated and
expressed as DHRmax. The quotient between maximal
heart rate and minimal heart rate after standing up was
calculated as T/B ratio (tachycardia/bradycardia ratio) [9].
Table 1 Demographic data and medication of the pancreatitis patient
Demographics
Patients 16
Sex (M/F) 10/6
Age (years), median (range) 49 (32–68)
Onset of pancreatitis, median (range) 5.5 (1–21.7)
Etiology
Alcohol 7
Idiopathic 7
Other (hereditary, hypertriglyceridemia-
induced pancreatitis)
2
Use of opioids 15
Morphine equivalents (mg), mean (range)a 146 (0–520)
Use of sedatives 2
Diabetes mellitus 4
a Opioid medication has been converted to Morphine Equivalents
(MEq) using the Narcotic Analgesic Converter (Version 2.0, Glob-
alRPh Inc.; www.GlobalRPh.com)
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Forced breathing. Each patient performed six maximal
respirations in 1 minute in the supine position, and both
inspiration and expiration were synchronized with the
program clock on the computer. Heart rate was computed
from the RR-interval and the difference between maximal
and minimal heart rate during each cycle of 10 seconds was
measured and averaged for the six respiratory cycles (I-E
difference) [9].
Valsalva maneuver. All patients were instructed to
maintain an expiratory pressure of 40 mmHg for 15 s by
means of forced expiration into a mouthpiece connected to
a manometer. The maneuver was performed in triplicate.
The maximum heart rate during the maneuver was divided
by the minimum heart rate after the manoeuvre (Valsalva
ratio) [10].
Plasma catecholamines
After voiding, a cannula was inserted in an antecubital vein
and a blood sample was drawn after 20 min of supine rest.
To assess the effects of mild sympathetic stimulation, a
second blood sample was drawn after 5 min of standing.
Blood samples were collected into chilled tubes containing
heparin and were immediately placed on ice. All samples
were centrifuged (at 4C) within 1 hour after blood sam-
pling and plasma samples were stored at -80C until
assayed for concentrations of norepinephrine (NE) and
epinephrine (EPI), using high-performance liquid chro-
matography [11]. All samples of each patient were assayed
within the same run. Intra-assay coefficients of variation
were 1.9% for NE and 3% for EPI. Interassay coefficients
of variation were 6.5% for NE and 11.4% for EPI.
Statistical analysis
For all variables, nonparametric tests were used. Preoper-
ative and postoperative data of the entire group were
compared using the paired Wilcoxon signed rank-sum test.
Relative and absolute differences between baseline and
standing NE and E levels (D) were calculated. We per-
formed statistical analysis using SPSS for Windows
(Release 13.0, SPSS Inc., Chicago, IL, USA). Demo-
graphic data are presented as median and range, and all
other data are presented as medians and interquartiles
(IQR). Differences were considered statistically significant
if P \ 0.05.
Results
In all 16 patients, BTS was technically successful, meaning
that all potentially nerve-bearing tissue on each side had
successfully been transected.
Hemodynamic effects of BTS
After BTS, supine as well as standing, both median systolic
and diastolic blood pressures were significantly lower than
before BTS (P \ 0.01; Table 2). This effect was observed
in all but two patients. The median supine systolic and
diastolic blood pressures were 10.5 mmHg (IQR
4–15.8 mmHg) and 7.5 mmHg (IQR 3–10.5 mmHg) lower
postoperatively. During standing the median differences
were 10.5 mmHg (IQR 7–27 mmHg) and 7.5 mmHg (IQR
1–17 mmHg), respectively. DBP increased significantly
with standing both before and after the operation
(2.5 mmHg (IQR -1 to 11 mmHg), P = 0.012, and
3 mmHg (IQR -1 to 7 mmHg, P = 0.049), whereas SBP
did not. One patient demonstrated orthostatic hypotension
before BTS, which persisted after the procedure. One
patient who had no orthostatic hypotension before BTS
demonstrated asymptomatic orthostatic hypotension after
BTS. Heart rate showed a similar increase with standing
both before and after BTS.
Table 2 Results of the
autonomic function testing pre
and postoperatively, depicted as
median (IQR)
P a P post BTS vs. pre-BTS,
P b P standing vs. supine
preoperatively and
P c P standing vs. supine
postoperatively
Pre-BTS Pb Post-BTS Pa Pc
Valsalva ratio 1.26 (1.13–1.54) 1.22 (1.17–1.88) 0.45
IE_difference 10 (8.4–17.1) 12.0 (6.7–15.8) 0.701
D HRmax 22 (16–31) 18 (16–25) 0.308
T/B ratio 1.11 (1.07–1.23) 1.1 (1.06–1.16) 0.181
SBP supine (mmHg) 108 (100–120) 0.856 102 (91–115) 0.028 0.074
SBP standing (mmHg) 109 (95–124) 97 (82–108) 0.01
DBP supine (mmHg) 63 (50–72) 0.012 57 (51–65) 0.005 0.016
DBP standing (mmHg) 67 (59–79) 60 (48–72) 0.016
MAP supine (mmHg) 78 (69–86) 72 (65–81) 0.009
MAP standing (mmHg) 78 (74–95) 71 (60–83) 0.013
HR supine (beats/min) 66 (62–75) \0.001 67 (61–75) 0.477 0.001
HR standing (beats/min) 83 (70–97)a 89 (71–103) 0.026
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Autonomic function tests
In all patients, the Valsalva ratio, the I-E difference, and
the DHR max were within normal limits before BTS and
were unaffected by BTS. The postoperative T/B ratio did not
differ significantly from the preoperative ratio (Table 2).
Plasma catecholamines
In two patients, both plasma EPI and NE levels after BTS
could not be measured for technical reasons.
Plasma NE levels
Before BTS, five patients showed higher supine plasma NE
levels than normal (upper limit NE 3.0 nmol/L), ranging
from 3.06–7.68 nmol/L. During standing, the plasma NE
levels of the entire group increased significantly from a
median 2.0 nmol/L (IQR 1.37–3.49) to a median 3.53 nmol/L
(IQR 2.52–5.94; P = 0.001). The median relative increment in
plasma NE was 89% (range 48–119%; Fig. 1A).
After BTS, baseline supine plasma NE level was
2.17 nmol/L (IQR 1.16–3.18), which was not significantly
different from the pre-BTS plasma NE level (P = 0.46). In
the upright position, plasma NE rose to 4.52 nmol/L (IQR
2.82–6.19; P \ 0.001), and the median relative increment
was slightly but significantly higher than before BTS
(100% vs. 89%; P = 0.011; Fig. 1B).
Plasma epinephrine levels
Before BTS, all patients had supine plasma EPI levels that
were within the normal range (median 0.08 (IQR
0.04–0.13) nmol/L). During standing plasma EPI levels
rose to median 0.12 nmol/L (IQR 0.06–0.16; P \ 0.001).
The relative increment of plasma EPI was 37% (IQR
21–66%; Fig. 1B).
After BTS, median supine plasma EPI level was
0.03 nmol/L (IQR 0.01–0.04) and significantly lower than
before BTS (P \ 0.001). After BTS, plasma EPI levels did
not increase after standing. In each individual patient, both
the supine and the standing plasma EPI levels were lower
after BTS. Consequently, both the relative and the absolute
increments in plasma EPI were significantly reduced after
BTS (P = 0.002 and P = 0.001, respectively; Fig. 1B).
Discussion
Interruption of sympathetic nerves by BTS for pain relief in
patients with chronic pancreatitis reduces baseline and
stimulated EPI plasma levels. In contrast, there is no effect
on sympathetic noradrenergic and parasympathetic func-
tion. Furthermore, the blood pressure was significantly
reduced after BTS.
Because the sympathetic nerves to the adrenal gland are
interrupted by BTS and because the adrenal medulla is
almost the sole source of circulating EPI, it is not surprising
that adrenomedullary function is impaired, which is reflected
by the decrease in plasma EPI levels. This effect has been
shown before in animal studies and for the first time now in
human subjects [12]. The present study cannot answer the
question of whether this selectively impaired adrenomedul-
lary function is of (patho-) physiological significance,
because we did not examine the plasma EPI responses, for
example, to strong stimuli, such as hypoglycemia, in these
patients. However, from animal studies it is known that
insulin-induced hypoglycemia detected in the portal vein is
Fig. 1 Boxplots of plasma norepinephrine (NE; A) and plasma
epinephrine (EPI; B) levels before (light boxes) and after (dark boxes)
the BTS. Dabsolute is the absolute increment of NE or EPI after
standing (pre = pre-BTS; post = post-BTS). On the right Y-axis, the
relative increment Drelative is depicted (%, right Y-axis) (A,
P = 0.001, *P = 0.011; B, P = 0.001, *P = 0.002, Wilcoxon
signed rank-sum test). Error bars represent range (minimum–
maximum)
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mediated through spinal sympathetic afferents and subse-
quently suppressed by sympathectomy [13, 14]. Theoreti-
cally, sympathectomy might have consequences for the
detection and regulation of glucose metabolism in diabetic
patients. In our diabetic patients, we did not encounter such
problems after BTS. Furthermore, we know from adrenal-
ectomized patients that depletion of EPI is tolerated well
[15, 16]. Although the adrenal cortex also is sympathetically
innervated, the main and predominant regulator of adrenal
cortical function is ACTH, released by the anterior pituitary
gland. Therefore, it is unlikely that adrenal cortical function
is impaired after BTS.
Noradrenergic sympathetic nerves supplying the
splanchnic vascular bed also are disrupted by BTS, but
plasma NE levels were unaltered, suggesting that overall
sympathetic nervous function is unimpaired. Although the
splanchnic vascular bed is richly innervated by sympathetic
nerves and the hepatic-mesenteric spillover amounts to
approximately 40%, a relatively low fraction of circulating
plasma NE is coming from the mesenteric organs, such as
pancreas and liver [17]. In addition, circulating plasma NE
is derived from sympathetic nerves from other organs, such
as skeletal muscle and heart; therefore, it is possible that
the local effect of BTS on splanchnic derived NE is
obscured. To uncover this local effect, more selective and
invasive measurements of NE spillover of the splanchnic
area would be necessary.
Variable effects on blood pressure have been reported
after thoracic sympathectomy. In contrast to Noppen et al.
[18], who found no effect, Kingma et al. [19] and Papa
et al. [20] demonstrated a decrease in resting BP after
sympathectomy as we did. From a physiological point of
view, the reduction can be attributed to vasodilatation due
to a reduced vascular resistance [19] or to a decrease in
cardiac output due to a decreased venous return. The lack
of a reflex-mediated increase in heart rate and plasma
catecholamines after BTS argues against the possibility of
substantial vasodilation. A direct cardiovascular effect
following denervation does not explain the hypotension in
our patients, because the majority of the cardiac sympa-
thetic plexus receives cardiac branches from above T5. In
patients who undergo sympathectomy for hyperhidrosis,
ganglia are transected at the levels T2–T4 through which
the direct sympathetic nerves serve the heart and more
cardiovascular effects are expected than after BTS [18–22].
Increased renal sympathetic activity causes hypertension
and sympathectomy is applied for the treatment of hyper-
tension [23–25]. Because the renal plexus receives fibers
from the lesser splanchnic nerves and the celiac plexus,
disruption of this anatomical and functional relation also
might explain the hypotensive effect of splanchnicectomy.
Only one patient demonstrated orthostatic hypotension
after BTS but was asymptomatic. Clinical significant
orthostatic hypotension has only been reported in a
minority of patients after both bilateral and unilateral
thoracoscopic splanchnicectomy for pain in chronic pan-
creatitis [26, 27].
Reduction of pain may be held responsible for lowering
blood pressure. Stress caused by pain causes an increase in
blood pressure, by increasing the muscle sympathetic nerve
activity [28]. However, the relationship of chronic pain and
blood pressure is less well understood and from some
studies it appears that this normal ‘‘pain–blood pressure’’
relationship is absent or reversed in patients with chronic
pain [29, 30]. This is supported by the fact that all our
patients were normotensive. Therefore, it is unlikely that
reduction in pain is responsible for causing orthostasis or
reduction in blood pressure in our group of patients.
Because variable effects of opioids on blood pressure
(increase as well as decrease) in normotensive as well as
hypertensive state have been reported, opioid use may have
affected the blood pressure in our patients [31, 32]. How-
ever, the opioid dose (expressed in MEq) was too diverse in
our patients to explain the unequivocal blood pressure
reduction measured in the majority of the patients.
Bilateral thoracoscopic splanchnicectomy is a surgical
procedure in which the splanchnic nerves are dissected by a
thoracoscopic approach. After 6 months follow-up 60–75%
of the patients have pain relief [33]. Because at least 25%
of patients do not experience any pain relief at all after
splanchnic deafferentation of the pancreas from the
beginning, complete splanchnic transsection could be
criticized in these patients. The finding of low EPI levels in
our cohort of patients in rest as well as after stimulation
post BTS, suggests complete technical success. Measuring
EPI concentrations before and after BTS therefore might be
a tool to verify complete denervation.
Bilateral splanchnicectomy does not seem to have sig-
nificant clinical side-effects. However, some caution is
warranted regarding the hypotensive effect, especially in
younger patients with a normal to low preoperative blood
pressure. In patients with hypertension, BTS may neces-
sitate adjustments in the antihypertensive treatment.
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